Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Oncologist|October 9, 2010
Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancerNicholas Thatcher, Jim Heighway
International Journal of Cancer|November 20, 2004
Induced expression of human CCND1 alternative transcripts in mouse Cyl-1 knockout fibroblasts highlights functional differencesSarah L Holley, Jim Heighway, Paul R Hoban
Lung Cancer (Amsterdam, Netherlands)|October 31, 2006
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformationOliver Gautschi, Daniel Ratschiller, Mathias Gugger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancerRichard Booton, Tim Ward, Linda Ashcroft, et al.
Journal of Muscle Research and Cell Motility|July 11, 2006
Over-expression of Microspan, a novel component of the sarcoplasmic reticulum, causes severe muscle pathology with triad abnormalitiesGaynor Miller, Angela K Peter, Erica Espinoza, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancerRichard Booton, Richard Booten, Tim Ward, et al.
Oncogene|December 4, 2003
Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesionsShirley L Smith, Suzanne G Watson, Daniel Ratschiller, et al.
Cancer|May 2, 2006
Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancerRichard Booton, Tim Ward, Jim Heighway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Aurora kinases as anticancer drug targetsOliver Gautschi, Jim Heighway, Philip C Mack, et al.
Clinical Colorectal Cancer|December 28, 2013
FOLFOX4 with cetuximab vs. UFOX with cetuximab as first-line therapy in metastatic colorectal cancer: The randomized phase II FUTURE studyJean-Yves Douillard, Tomasz Zemelka, George Fountzilas, et al.
Pageof 2